What is Quviviq (daridorexant) and what does “Indorsia” mean?
“Quviviq” is a brand name for daridorexant, a prescription medicine used for the treatment of adults with insomnia (it targets orexin signaling). The term “Indorsia” isn’t a standard medical or regulatory label term for Quviviq in general usage, so the meaning depends on where you saw it (for example, a specific distributor/pharmacy program, a country-specific brand listing, or a company name).
Where might you have seen “Indorsia,” and how can you verify it?
If you saw “Indorsia” next to Quviviq on a website, invoice, label, or press post, it could refer to:
- A distributor or local partner company name for sales/marketing
- A marketplace/supplier listing name (not necessarily the manufacturer)
- A country/region-specific reference
The fastest way to confirm is to check the document you’re looking at for either:
- The marketing authorization holder / MAH name
- The manufacturer or packager listed on the box/leaflet
- A country code or regulatory agency reference
If you share the exact text (and country/website where you saw “Indorsia”), I can map it to what it likely refers to.
Who makes Quviviq (daridorexant)?
I can confirm the manufacturer/marketer details if you provide the jurisdiction (country) or the exact source you’re using. Brand and “company listed” details can change by market.
How do you find the official Quviviq labeling for your country?
Look for the package insert or regulatory summary in your country’s official medicines database, then match:
- Ingredient name: daridorexant
- Strengths and dosage form
- Company names (MAH, manufacturer)
If you tell me the country, I can guide you on what to look for in that system and how to interpret it.
Can you send the link or a screenshot?
To answer precisely what “Quviviq indorsia” refers to, send the link or paste the sentence where you saw “Indorsia” (including any country name).